CFTR and cystic fibrosis: This is a relevant aspect, considering that several CFTR modulators have not been effective in F508del heterozygotes or carrying nonsense mutations [64]; and (iii) to maintain their antibacterial activity (using P. aeruginosa as a model microorganism) under conditions mirroring CF lung.